Ditch the Tenaculum.
Use Anatomically Adaptive Technology.
Finally, a standardized and simplified approach to trans-cervical intra-uterine procedures.
Because patients and Gyn providers deserve better.
Transforming Gyn and Infertility Procedures.
With CrossGlide Technology, IUD’s are being placed without a tenaculum or a uterine sound. But the innovation doesn’t need to stop there.
Now, with Euva, we’re bringing the same trusted, and proven anatomically adaptive technology to transform the standard of care for Gyn and Infertility procedures.
Now Approved!
It’s about time. We’re changing how infertility procedures, starting with endometrial biopsy, and embryo transfer. Contact us to learn how your team can standardize uterine access.
Better patient experience and satisfaction
Easier, more efficient procedures
Reduced pain and discomfort
No uterine manipulation or full bladders
No tenaculum
Better visualization
Our portfolio continues to expand, with broader applications coming soon
Our technology has a range of applications such as intrauterine insemination, tubal patency, hysteroscopy, and more. Today, we’re approved for endometrial biopsy and embryo transfers, with more on the horizon. We’re actively raising capital to finalize the development and FDA clearance for 3 others.
Imagine the opportunities for anatomically adaptive technology. Join us as we eliminate the need for a tenaculum for good.
Our Story & Mission.
First, we tackled IUD insertion pain head-on, long before it was talked about or trending. We developed modern technology that doesn’t just dismiss procedural pain, but instead validates and solves it.
Euva Global is a growing product portfolio tailored to meet the needs of Gyn and infertility procedures typically performed in a physicians’ office. Euva was born from CrossBay, a company that was founded 15 years ago on the principle that women deserve a better experience.
Leveraging CrossGlide technology developed by CrossBay, we’ve embarked on a new mission with the same anatomically adaptive technology to tackle trans-cervical uterine access during infertility diagnostic and therapeutic procedures.
Hear what doctors have to say…
-
![testimonial]()
Dr. Charles Kingsland, Chief Medical Officer for Conceivable Life Sciences and Clinical Director for Care Fertility in the UK
“Your invention is the best thing I've seen in IVF since time lapse and in vitro culture, seriously. I often say, something comes along every five years that significantly alters the way we practice IVF. This, in my opinion, is one of those things.”
-
![testimonial 2]()
Alison Campbell, Chief Scientific Officer, Care Fertility and Fellow Royal College of Pathologists
“This technology is exciting! I think it has the potential to make embryo transfer and other interventions easier to perform and more comfortable for patients. Embryo transfer catheters have undergone very little development since the beginning of IVF, so I’m excited about this technology and I’d expect it to improve patient experience and have a positive impact on clinical outcomes. Both highly important.”
